Identification |
Name: | 1,3-Dioxolo[4,5-g]isoquinolinium,5-[(6S)-6,8-dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl]-5,6,7,8-tetrahydro-6,6-dimethyl-,bromide (1:1), (5R)- |
Synonyms: | 1,3-Dioxolo[4,5-g]isoquinolinium,5-(6,8-dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl)-5,6,7,8-tetrahydro-6,6-dimethyl-,bromide, [S-(R*,S*)]-;1,3-Dioxolo[4,5-g]isoquinolinium,5-[(6S)-6,8-dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl]-5,6,7,8-tetrahydro-6,6-dimethyl-,bromide, (5R)- (9CI);(-)-Bicuculline methobromide; |
CAS: | 73604-30-5 |
Molecular Formula: | C21H20 N O6 . Br |
Molecular Weight: | 462.29 |
Molecular Structure: |
|
Properties |
Transport: | UN 1544 6.1/PG 2 |
Water Solubility: | aqueous base: unstable |
Solubility: | aqueous base: unstable |
Appearance: | white |
Specification: | Safety Statements:24/25 24/25:Avoid contact with skin and eyes |
Packinggroup: | III |
Biological Activity: | Methobromide salt of (+)-bicuculline ([R-(R*,S*)]-6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)furo[3,4-e]-1,3-benzodioxol-8(6H)-one ). Water soluble and more stable than bicuculline. Non-GABA receptor-mediated actions reported. |
Storage Temperature: | 2-8°C |
Color: | white |
Safety Data |
|
|